A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea

NCT04713826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG: BAY2586116
DRUG: Placebo

Sponsor

Bayer